Metzenauer P - Search Results

1

Effects of the novel beta-adrenergic partial agonist alifedrine on cardiac performance in dogs with acute ischemic left ventricular failure.

Metzenauer P, Dedecke R, Göbel H, Martorana PA, Stroman F, Szelenyi I. Metzenauer P, et al. J Cardiovasc Pharmacol. 1989 Jul;14(1):103-8. doi: 10.1097/00005344-198907000-00018. J Cardiovasc Pharmacol. 1989. PMID: 2475700

2

5-HT1A-agonistic properties of naftopidil, a novel antihypertensive drug.

Borbe HO, Metzenauer P, Szelenyi I. Borbe HO, et al. Among authors: metzenauer p. Eur J Pharmacol. 1991 Nov 19;205(1):105-7. doi: 10.1016/0014-2999(91)90779-p. Eur J Pharmacol. 1991. PMID: 1839829

3

Young domestic pigs for the cardiovascular assessment of inotropic drugs. Comparison with dogs.

Stroman F, Metzenauer P. Stroman F, et al. Among authors: metzenauer p. J Pharmacol Methods. 1988 Jul;19(4):355-63. doi: 10.1016/0160-5402(88)90008-3. J Pharmacol Methods. 1988. PMID: 2899656

4

[The pharmacology of a new cardiosteroid, a partially synthetic derivative of the aglycone hellebrigenin (acrihellin)].

Stroman F, Jakovlev V, Metzenauer P, Roth E, Thiemer K. Stroman F, et al. Among authors: metzenauer p. Arzneimittelforschung. 1984;34(7):769-79. Arzneimittelforschung. 1984. PMID: 6541912 German.

5

5-HT3 receptor antagonism by anpirtoline, a mixed 5-HT1 receptor agonist/5-HT3 receptor antagonist.

Göthert M, Hamon M, Barann M, Bönisch H, Gozlan H, Laguzzi R, Metzenauer P, Nickel B, Szelenyi I. Göthert M, et al. Among authors: metzenauer p. Br J Pharmacol. 1995 Jan;114(2):269-74. doi: 10.1111/j.1476-5381.1995.tb13222.x. Br J Pharmacol. 1995. PMID: 7881726 Free PMC article.

6

Anxiolytic-like actions of anpirtoline in a mouse light-dark aversion paradigm.

Metzenauer P, Barnes NM, Costall B, Gozlan H, Hamon M, Kelly ME, Murphy DA, Naylor RJ. Metzenauer P, et al. Neuroreport. 1992 Jun;3(6):527-9. doi: 10.1097/00001756-199206000-00019. Neuroreport. 1992. PMID: 1356500

7

Comparison of azelastine eye drops with levocabastine eye drops in the treatment of seasonal allergic conjunctivitis.

Giede C, Metzenauer P, Petzold U, Ellers-Lenz B. Giede C, et al. Among authors: metzenauer p. Curr Med Res Opin. 2000;16(3):153-63. Curr Med Res Opin. 2000. PMID: 11191004 Clinical Trial.

8

Efficacy and safety of formoterol delivered through the Novolizer, a novel dry powder inhaler (DPI) compared with a standard DPI in patients with moderate to severe asthma.

Otto-Knapp R, Conrad F, Hösch S, Metzenauer P, Maus J, Noga O, Petzold U, Kunkel G. Otto-Knapp R, et al. Among authors: metzenauer p. Pulm Pharmacol Ther. 2008;21(1):47-53. doi: 10.1016/j.pupt.2006.11.003. Epub 2006 Dec 14. Pulm Pharmacol Ther. 2008. PMID: 17475527 Clinical Trial.

9

Differential effects of new-generation H1-receptor antagonists in pruritic dermatoses.

Henz BM, Metzenauer P, O'Keefe E, Zuberbier T. Henz BM, et al. Among authors: metzenauer p. Allergy. 1998 Feb;53(2):180-3. doi: 10.1111/j.1398-9995.1998.tb03867.x. Allergy. 1998. PMID: 9534917 Clinical Trial.

10

Once versus twice daily formoterol via Novolizer for patients with moderate to severe COPD--a double-blind, randomised, controlled trial.

Welte T, Metzenauer P, Hartmann U. Welte T, et al. Among authors: metzenauer p. Pulm Pharmacol Ther. 2008;21(1):4-13. doi: 10.1016/j.pupt.2006.09.002. Epub 2006 Oct 20. Pulm Pharmacol Ther. 2008. PMID: 17101285 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters